Company Filing History:
Years Active: 2025
Title: Matthew R. Vogt: Innovator in Monoclonal Antibodies
Introduction
Matthew R. Vogt is a prominent inventor based in Nashville, TN (US). He has made significant contributions to the field of biomedical research, particularly in the development of human monoclonal antibodies. His work focuses on addressing critical health challenges posed by viral infections.
Latest Patents
Matthew R. Vogt holds a patent for "Human monoclonal antibodies to enterovirus D68." This patent is directed towards human and engineered antibodies that bind to enterovirus D68 (EV-D68). The patent also covers engineered cells that produce these antibodies and outlines methods for diagnosing and treating EV-D68 infections. Additionally, it includes vaccine formulations that comprise one or more of the antibodies and fragments, as well as vectors encoding the same.
Career Highlights
Matthew R. Vogt is affiliated with Vanderbilt University, where he conducts his research. His work has been instrumental in advancing the understanding of enterovirus D68 and developing therapeutic strategies to combat infections caused by this virus.
Collaborations
He collaborates with notable researchers in the field, including James E. Crowe, Jr. Their combined expertise enhances the potential for innovative solutions in viral infection treatment.
Conclusion
Matthew R. Vogt's contributions to the field of monoclonal antibodies represent a significant advancement in medical research. His innovative work continues to pave the way for new therapeutic options against viral infections.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.